Mercia Knowledge Intensive Impact Fund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Enables CE Marking of blood test for brain cancer and advances colorectal cancer development Dxcover Limited, a clinical-stage diagnostics company developing spectroscopic liquid biopsy technology

United statesUnited kingdomAndrew mcneillLauren arnoldMark hegartyMatthewj bakerThairm bioSchwierige zeitenMark bamforthMercia asset managementEuropean innovation councilMercia knowledge intensive impact fundUniversity of strathclydeNeos advisoryLiquid biopsy platformScottish enterprise